ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.

Carmela Passaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.